Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Price to Sales Ratio 2010-2024 | MKKGY

Historical PS ratio values for Merck (MKKGY) over the last 10 years. The current P/S ratio for Merck as of December 09, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Merck P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.973B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.613B 30.64
Takeda Pharmaceutical (TAK) Japan $43.687B 9.09
Astellas Pharma (ALPMY) Japan $19.038B 17.53
Sandoz Group AG (SDZNY) Switzerland $18.830B 0.00
United Therapeutics (UTHR) United States $16.504B 16.24
Summit Therapeutics (SMMT) United States $13.672B 0.00
Neurocrine Biosciences (NBIX) United States $12.974B 34.35
Shionogi (SGIOY) Japan $12.522B 12.55
Catalent (CTLT) United States $11.223B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.998B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.368B 48.24
Ionis Pharmaceuticals (IONS) United States $6.017B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.459B 0.00
PTC Therapeutics (PTCT) United States $3.705B 0.00
Dyne Therapeutics (DYN) United States $3.002B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.626B 11.90
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.618B 15.65
Centessa Pharmaceuticals (CNTA) United Kingdom $2.462B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.296B 0.00
Soleno Therapeutics (SLNO) United States $2.119B 0.00
Xencor (XNCR) United States $1.773B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.695B 0.00
Evotec AG (EVO) Germany $1.634B 0.00
Guardian Pharmacy Services (GRDN) United States $1.582B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.576B 0.00
Indivior (INDV) United States $1.565B 6.38
Ocular Therapeutix (OCUL) United States $1.512B 0.00
Harrow (HROW) United States $1.400B 0.00
ARS Pharmaceuticals (SPRY) United States $1.363B 0.00
Ardelyx (ARDX) United States $1.355B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.279B 0.00
Enliven Therapeutics (ELVN) United States $1.242B 0.00
Collegium Pharmaceutical (COLL) United States $0.967B 5.28
Avadel Pharmaceuticals (AVDL) Ireland $0.964B 0.00
Bioventus (BVS) United States $0.948B 29.95
Cronos Group (CRON) Canada $0.780B 0.00
Relay Therapeutics (RLAY) United States $0.772B 0.00
Oruka Therapeutics (ORKA) United States $0.742B 0.00
USANA Health Sciences (USNA) United States $0.711B 13.18
Esperion Therapeutics (ESPR) United States $0.686B 0.00
Tourmaline Bio (TRML) United States $0.665B 0.00
Altimmune (ALT) United States $0.648B 0.00
Elite Pharmaceuticals (ELTP) United States $0.645B 0.00
Savara (SVRA) United States $0.638B 0.00
ProKidney (PROK) United States $0.604B 0.00
OmniAb (OABI) United States $0.568B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.549B 0.00
Verve Therapeutics (VERV) United States $0.548B 0.00
Xeris Biopharma Holdings (XERS) United States $0.547B 0.00
Siga Technologies (SIGA) United States $0.497B 5.80
Zevra Therapeutics (ZVRA) United States $0.488B 0.00
Organogenesis (ORGO) United States $0.488B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.448B 181.79
Akebia Therapeutics (AKBA) United States $0.447B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Korro Bio (KRRO) United States $0.399B 0.00
Aquestive Therapeutics (AQST) United States $0.380B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.352B 0.00
Avita Medical (RCEL) United States $0.343B 0.00
4D Molecular Therapeutics (FDMT) United States $0.340B 0.00
Aldeyra Therapeutics (ALDX) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.60
Aclaris Therapeutics (ACRS) United States $0.281B 0.00
Lyell Immunopharma (LYEL) United States $0.264B 0.00
Silence Therapeutics (SLN) United Kingdom $0.255B 0.00
Lexeo Therapeutics (LXEO) United States $0.252B 0.00
Heron Therapeutics (HRTX) United States $0.246B 0.00
Inhibikase Therapeutics (IKT) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.200B 0.00
Telomir Pharmaceuticals (TELO) United States $0.193B 0.00
Nektar Therapeutics (NKTR) United States $0.188B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
MediWound (MDWD) Israel $0.183B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cassava Sciences (SAVA) United States $0.155B 0.00
VAXART, INC (VXRT) United States $0.143B 0.00
Nanobiotix S.A (NBTX) France $0.141B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Century Therapeutics (IPSC) United States $0.129B 0.00
Galectin Therapeutics (GALT) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.118B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Journey Medical (DERM) United States $0.112B 0.00
Fractyl Health (GUTS) United States $0.111B 0.00
Avalo Therapeutics (AVTX) United States $0.106B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Pyxis Oncology (PYXS) United States $0.099B 0.00
Inotiv (NOTV) United States $0.099B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.090B 23.53
Arch Biopartners (ACHFF) Canada $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
OptiNose (OPTN) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Iterum Therapeutics (ITRM) Ireland $0.074B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.069B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
AlloVir (ALVR) United States $0.058B 0.00
Scienture Holdings (SCNX) United States $0.057B 0.00
CASI Pharmaceuticals (CASI) China $0.056B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.055B 0.00
BioVie (BIVI) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.046B 0.00
Nutriband (NTRB) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.034B 0.00
Carisma Therapeutics (CARM) United States $0.033B 0.00
Surrozen (SRZN) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.025B 0.00
DURECT (DRRX) United States $0.025B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Biomerica (BMRA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.90
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 40.16